|
|
|
40
|
1542A
|
DIAMIN 25MG TAB (RLS/AHI) IMIPRAMINE
|
IMIPRAMINE
|
DIAMIN
|
200'S
|
A
|
18.87
|
0.09
|
TABLET
|
240
|
TAB
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160428
|
TRICYCLICS & OTHER NOREPINEPHRINE REUPTAKE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
3081Y
|
IMMUNOREL 5% INJ (RLS/AHI) IMMUNOGLOBULIN
|
IMMUNOGLOBULIN HUMAN
|
IMMUNOREL
|
100ML
|
BQ
|
657.29
|
657.29
|
INJECTION
|
0
|
BOTT
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
SERUMS, TOXOIDS AND VACCINES
|
|
|
|
|
41
|
3081Y
|
IMMUNOREL 5% INJ (RLS) IMMUNOGLOBUL (BQ)
|
IMMUNOGLOBULIN HUMAN
|
IMMUNOREL
|
100ML
|
BQ
|
807.34
|
807.3422
|
BOTT
|
0
|
BOTT
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
SERUMS
|
|
|
|
|
42
|
3081Y
|
IMMUNOREL 5% INJ (RLS) IMMUNOGLOBUL
|
IMMUNOGLOBULIN HUMAN
|
IMMUNOREL
|
100ML
|
BQ
|
807.34
|
807.34
|
BOTT
|
0
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2026-04-01
|
|
|
IV
|
0
|
SERUMS
|
|
|
|
|
41
|
3082A
|
IMMUNOREL 10% INJ (RLS) IMMUNOGLOBU (BQ)
|
IMMUNOGLOBULIN
|
IMMUNOREL
|
100ML
|
BQ
|
1353.73
|
1353.7254
|
VIAL
|
50
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
SERUMS
|
|
|
|
|
40
|
31717
|
ADALIREL 40MG INJ (RLS/AHI) ADALIMUMAB
|
ADALIMUMAB
|
ADALIREL
|
0.8ML SYRN
|
C
|
875.30
|
875.30
|
INJECTION
|
0
|
PFS
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4181BK
|
INFLIXIRIL 100MG INJ (RLS/AHI) INFLIXIMAB
|
INFLIXIMAB
|
INFLIXIRIL
|
100ML
|
C
|
1,058.52
|
1,058.52
|
INJECTION
|
0
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4181BR
|
BEVACIREL 25MG/ML INJ (RLS) BEVACIZUMAB (C)
|
BEVACIZUMAB
|
BEVACIREL
|
4ML VIAL
|
C
|
430.58
|
430.5825
|
VIAL
|
0
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
41
|
4181N
|
RITUXIMAB 10MG/ML INJ (RLS) (BQ)
|
RITUXIMAB
|
RITUXIMAB
|
10ML
|
BQ
|
190.01
|
190.0108
|
VIAL
|
0
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
1000
|
ANTINEOPLASTICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
ANTINEOPLASTICS
|
|
|
|
|
40
|
4582P
|
HEMOREL A 500IU INJ (RLS/AHI) FACTOR VIII
|
FACTOR VIII
|
HEMOREL A
|
500IU VIAL
|
BQ
|
330.28
|
330.28
|
INJECTION
|
0
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
202816
|
HEMOSTATICS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
4582P
|
HEMOREL A 500IU INJ (RLS) FACTOR VI (BQ)
|
FACTOR VIII
|
HEMOREL A
|
500IU VIAL
|
BQ
|
305.81
|
305.8115
|
VIAL
|
12
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
202816
|
HEMOSTATICS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
HEMOSTATICS
|
|
|
|
|
42
|
4582P
|
HEMOREL A 500IU INJ (RLS) FACTOR VI
|
FACTOR VIII
|
HEMOREL A
|
500IU VIAL
|
BQ
|
309.48
|
309.48
|
VIAL
|
12
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
202816
|
HEMOSTATICS
|
2026-04-01
|
|
|
IV
|
0
|
HEMOSTATICS
|
|
|
|
|
42
|
49418
|
ALBUREL 25% INJ (RLS) ALBUMIN
|
ALBUMIN
|
ALBUREL
|
50ML
|
BQ
|
127.87
|
127.87
|
VIAL
|
40
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
8004
|
SERUMS
|
2026-04-01
|
|
|
IV
|
0
|
SERUMS
|
|
|
|
|
40
|
7691C
|
INTERFERON ALPHA 2B 3MU INJ (RLS/AHI)
|
INTERFERON ALPHA 2B
|
INTERFERON ALPHA 2B
|
3MU VIAL
|
C
|
49.72
|
49.72
|
INJECTION
|
0
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081820
|
INTERFERONS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
7691C
|
INTERFERON ALPHA 2B 3MU INJ (RLS)
|
INTERFERON ALPHA 2B
|
INTERFERON ALPHA 2B
|
3MU VIAL
|
C
|
23.65
|
23.6494
|
VIAL
|
0
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081820
|
INTERFERONS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
INTERFERONS
|
|
|
|
|
42
|
7691D
|
RELIFERON 300MU/0.5ML INJ (RLS) INTERFERON ALPHA 2B
|
INTERFERON ALPHA 2B
|
RELIFERON
|
3MU VIAL
|
BQ
|
24.14
|
24.14
|
VIAL
|
0
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
081820
|
INTERFERONS
|
2026-04-01
|
|
|
SC
|
0
|
INTERFERONS
|
|
|
|
|
40
|
B4913
|
OMALIREL 150MG INJ (RLS/AHI) OMALIZUMAB
|
OMALIZUMAB
|
OMALIREL
|
150MG VIAL
|
C
|
844.86
|
844.86
|
INJECTION
|
0
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4810
|
RESPIRATORY INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
RESPIRATORY TRACT AGENTS
|
|
|
|
|
41
|
B4913
|
OMALIREL 150MG INJ (RLS) OMALIZUMAB (C)
|
OMALIZUMAB
|
OMALIREL
|
150MG VIAL
|
C
|
844.86
|
844.8551
|
VIAL
|
0
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4810
|
RESPIRATORY INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
RESPIRATORY INFLAMMATORY AGENTS
|
|
|
|
|
42
|
B4913
|
OMALIREL 150MG INJ (RLS) OMALIZUMAB
|
OMALIZUMAB
|
OMALIREL
|
150MG VIAL
|
BQ
|
747.54
|
747.54
|
VIAL
|
0
|
VIAL
|
RLS
|
RELIANCE LIFE SCIENCES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4810
|
RESPIRATORY INFLAMMATORY AGENTS
|
2026-04-01
|
|
|
IV
|
0
|
RESPIRATORY INFLAMMATORY AGENTS
|
|
